Paired with an image viewer, Optra SCAN facilitates complete customization of viewing and enhanced image display. It allows seamless integration with best-in-class companion software and provides these benefits through one of the most user-friendly and intuitive interfaces available.
Along with an image viewer, the integrated companion software comprises of Optra ASSAYS and Optra IMAGEPath as part of the fully integrated digital pathology system. This makes the Optra SCAN a comprehensive package for effective acquisition, viewing, analysis and management of digital slides and associated metadata.
Optra SCAN serves as a perfect tool for transition from conventional microscopy to digital pathology!
Overview
Mentions in press and media 14
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 9, 2026 | OptraSCAN System Receives FDA Clearance | FDA 510(k) clearance (K260755) for the OptraSCAN System, an integrated platform featuring the OS-Ultra Scanner and ImagePath software with HER2 Image Analysis. This first clearance further strengthens OptraSCAN’s mission to make Digital Pat... |
| Mar 17, 2026 | OptraSCAN Launches HistoSiA™ Breast Pay-Per-Use: Scan, Analyze & Auto-Segregate Breast Cancer IHC Cases in One Workflow | HistoSiA™ Breast Pay-Per-Use Solution AI-enabled platform auto-categorizes HER2 cases during scanning, allowing pathologists to review pre-analyzed results and boost diagnostic throughput HistoSiA™ Breast enables laboratories to shift manua... |
| Aug 5, 2025 | OptraSCAN Launches AI-Powered CytoSiA Platform at 9th Digital Pathology & AI Congress: Asia, Singapore | OptraSCAN's CytoSiA Effectively Screen Liquid-Based Cytology Slides And Pap Smears AI-Powered Cytology Platform Expands Access and Accuracy for Cervical Cancer Screening Across Asia—Aligned with WHO’s 90-70-90 Elimination Goals Digital cyto... |
| Mar 24, 2025 | OptraSCAN Strengthens Leadership and Advisory Board to Drive Global Digital Pathology Innovation | OptraSCAN extended Medical Advisory Board and Leadership Team OptraSCAN expands post-Series B, adding top advisors and leaders to advance AI-powered digital pathology and global market growth. SAN JOSE , CA, UNITED STATES, March 24, 2025 /E... |
| Aug 8, 2023 | OptraSCAN Empowers AIG Hospitals with Digital Pathology Solutions | Hyderabad, Telangana, India OptraSCAN, a global leader in digital pathology solutions, is delighted to announce the successful implementation and utilization of its high-speed Digital Pathology Platform OS-Ultra by AIG Hospitals (A unit of ... |
| May 2, 2023 | Lumea and OptraSCAN Announce Partnership to Enable Seamless Adoption of Digital Pathology | Lumea, global leader in integrated digital pathology solutions & OptraSCAN, a top end-to-end digital pathology solution provider, announced a collaboration. LEHI, UTAH, USA, May 2, 2023/EINPresswire.com/ -- Lumea, a global leader in int... |
| Apr 27, 2023 | Lumea and OptraSCAN Announce Partnership to Enable Seamless Adoption of Digital Pathology | Lumea, the leader in integrated digital pathology, & OptraSCAN, the top end-to-end digital pathology solution provider, announced a collaboration agreement. LEHI, UTAH, UNITED STATES, April 27, 2023/EINPresswire.com/ -- Lumea, a global ... |
| May 30, 2022 | AI Equipped OS-SiA Digital Pathology Scanner Developed by OptraSCAN Granted US Patent | Pune, Maharashtra, India OptraSCAN®, the leading end-to-end digital pathology solution provider, announced its digital pathology scanner OS-SiA has been granted US patent - No 2020/0334814 A1 by the United States Patent and Trademark Office... |
| May 24, 2022 | OptraSCAN's Artificial Intelligence-Equipped Digital Pathology Scanner OS-SiA Granted U.S Patent for Scanning, Indexing and Analyzing of the Tissue Area at the Same Time | SAN JOSE, Calif., May 24, 2022 /PRNewswire/ -- OptraSCAN®, the leading end-to-end digital pathology solution provider, announced its digital pathology scanner OS-SiA has been granted US patent - No 2020/0334814 A1 by the United States Paten... |
Reviews 0
FAQ about OptraSCAN
When was OptraSCAN founded?
OptraSCAN was founded in 2015.
What has the press written about OptraSCAN?
Parsers VC has collected 14 articles mentioning OptraSCAN, among them “OptraSCAN System Receives FDA Clearance” (Jul 9, 2026) and “OptraSCAN Launches HistoSiA™ Breast Pay-Per-Use: Scan, Analyze & Auto-Segregate Breast Cancer IHC Cases in One Workflow” (Mar 17, 2026).
Is OptraSCAN still active?
Yes, OptraSCAN is active; its latest activity on Parsers VC dates from Oct 13, 2026.